Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Amifostine is a pro-drug which is activated to the free thiol metabolite at the tissue site. The thiol metabolite is responsible for most of the cytoprotective and radioprotective properties of amifostine. It is readily taken up by cells where it binds to and detoxifies reactive metabolites of platinum and alkylating agents as well as scavenges free radicals. Other possible effects include inhibition of apoptosis, alteration of gene expression and modification of enzyme activity. Healthy cells are preferentially protected because amifostine and metabolites are present in healthy cells at 100-fold greater concentrations than in tumour cells.
Amifostine shows a good effect in reducing harmful effects of cisplatin chemotherapy on kidneys in women treated for advanced ovarian cancer as well as relieving dry mouth problems (xerostomia) with head and neck cancer patients undergoing radiation treatment. It is estimated that the amifostine market will keep an upward tendency.
The prevalence of target diseases, the increasing demand for early detection of incurable diseases and the emergence of innovative applications, the market of amifostine is rapidly developing, people's preference for instant testing and personalized drugs is growing, and cost-effective laboratory testing And the emergence of integrated analysis systems is expected to bring new opportunities to businessmen in this market.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Amifostine market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Amifostine market. Detailed analysis of key players, along with key growth strategies adopted by Amifostine industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Taj Pharmaceuticals
Clinigen Group
Mingren Pharma
Sun Pharmaceutical
Merro Pharmaceutical
Luye Pharma
By Type:
400mg/Dose
500mg/Dose
By End-User:
Ovarian Cancer Adjuvant Therapy
Head and Neck Cancer Adjuvant Therapy
Others
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Amifostine Market
-
1.3 Market Segment by Type
-
1.3.1 China Amifostine Market Size and Growth Rate of 400mg/Dose from 2016 to 2027
-
1.3.2 China Amifostine Market Size and Growth Rate of 500mg/Dose from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Amifostine Market Size and Growth Rate of Ovarian Cancer Adjuvant Therapy from 2016 to 2027
-
1.4.2 China Amifostine Market Size and Growth Rate of Head and Neck Cancer Adjuvant Therapy from 2016 to 2027
-
1.4.3 China Amifostine Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Amifostine Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Amifostine Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Amifostine Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Amifostine Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Amifostine Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Amifostine Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Amifostine Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Amifostine Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Amifostine by Major Types
-
3.4.1 Market Size and Growth Rate of 400mg/Dose
-
3.4.2 Market Size and Growth Rate of 500mg/Dose
4 Segmentation of Amifostine Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Amifostine by Major End-Users
-
4.4.1 Market Size and Growth Rate of Amifostine in Ovarian Cancer Adjuvant Therapy
-
4.4.2 Market Size and Growth Rate of Amifostine in Head and Neck Cancer Adjuvant Therapy
-
4.4.3 Market Size and Growth Rate of Amifostine in Others
5 Market Analysis by Regions
-
5.1 China Amifostine Production Analysis by Regions
-
5.2 China Amifostine Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Amifostine Landscape Analysis
-
6.1 North China Amifostine Landscape Analysis by Major Types
-
6.2 North China Amifostine Landscape Analysis by Major End-Users
7 Central China Amifostine Landscape Analysis
-
7.1 Central China Amifostine Landscape Analysis by Major Types
-
7.2 Central China Amifostine Landscape Analysis by Major End-Users
8 South China Amifostine Landscape Analysis
-
8.1 South China Amifostine Landscape Analysis by Major Types
-
8.2 South China Amifostine Landscape Analysis by Major End-Users
9 East China Amifostine Landscape Analysis
-
9.1 East China Amifostine Landscape Analysis by Major Types
-
9.2 East China Amifostine Landscape Analysis by Major End-Users
10 Northeast China Amifostine Landscape Analysis
-
10.1 Northeast China Amifostine Landscape Analysis by Major Types
-
10.2 Northeast China Amifostine Landscape Analysis by Major End-Users
11 Southwest China Amifostine Landscape Analysis
-
11.1 Southwest China Amifostine Landscape Analysis by Major Types
-
11.2 Southwest China Amifostine Landscape Analysis by Major End-Users
12 Northwest China Amifostine Landscape Analysis
-
12.1 Northwest China Amifostine Landscape Analysis by Major Types
-
12.2 Northwest China Amifostine Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Taj Pharmaceuticals
-
13.1.1 Taj Pharmaceuticals Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Clinigen Group
-
13.2.1 Clinigen Group Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Mingren Pharma
-
13.3.1 Mingren Pharma Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Sun Pharmaceutical
-
13.4.1 Sun Pharmaceutical Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Merro Pharmaceutical
-
13.5.1 Merro Pharmaceutical Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Luye Pharma
-
13.6.1 Luye Pharma Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Amifostine Market Size and Growth Rate of 400mg/Dose from 2016 to 2027
-
Figure China Amifostine Market Size and Growth Rate of 500mg/Dose from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Amifostine Market Size and Growth Rate of Ovarian Cancer Adjuvant Therapy from 2016 to 2027
-
Figure China Amifostine Market Size and Growth Rate of Head and Neck Cancer Adjuvant Therapy from 2016 to 2027
-
Figure China Amifostine Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Amifostine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Amifostine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Amifostine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Amifostine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Amifostine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Amifostine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Amifostine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Amifostine Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Amifostine
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Amifostine by Different Types from 2016 to 2027
-
Table Consumption Share of Amifostine by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of 400mg/Dose
-
Figure Market Size and Growth Rate of 500mg/Dose
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Amifostine by Different End-Users from 2016 to 2027
-
Table Consumption Share of Amifostine by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Ovarian Cancer Adjuvant Therapy
-
Figure Market Size and Growth Rate of Head and Neck Cancer Adjuvant Therapy
-
Figure Market Size and Growth Rate of Others
-
Table China Amifostine Production by Regions
-
Table China Amifostine Production Share by Regions
-
Figure China Amifostine Production Share by Regions in 2016
-
Figure China Amifostine Production Share by Regions in 2021
-
Figure China Amifostine Production Share by Regions in 2027
-
Table China Amifostine Consumption by Regions
-
Table China Amifostine Consumption Share by Regions
-
Figure China Amifostine Consumption Share by Regions in 2016
-
Figure China Amifostine Consumption Share by Regions in 2021
-
Figure China Amifostine Consumption Share by Regions in 2027
-
Table North China Amifostine Consumption by Types from 2016 to 2027
-
Table North China Amifostine Consumption Share by Types from 2016 to 2027
-
Figure North China Amifostine Consumption Share by Types in 2016
-
Figure North China Amifostine Consumption Share by Types in 2021
-
Figure North China Amifostine Consumption Share by Types in 2027
-
Table North China Amifostine Consumption by End-Users from 2016 to 2027
-
Table North China Amifostine Consumption Share by End-Users from 2016 to 2027
-
Figure North China Amifostine Consumption Share by End-Users in 2016
-
Figure North China Amifostine Consumption Share by End-Users in 2021
-
Figure North China Amifostine Consumption Share by End-Users in 2027
-
Table Central China Amifostine Consumption by Types from 2016 to 2027
-
Table Central China Amifostine Consumption Share by Types from 2016 to 2027
-
Figure Central China Amifostine Consumption Share by Types in 2016
-
Figure Central China Amifostine Consumption Share by Types in 2021
-
Figure Central China Amifostine Consumption Share by Types in 2027
-
Table Central China Amifostine Consumption by End-Users from 2016 to 2027
-
Table Central China Amifostine Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Amifostine Consumption Share by End-Users in 2016
-
Figure Central China Amifostine Consumption Share by End-Users in 2021
-
Figure Central China Amifostine Consumption Share by End-Users in 2027
-
Table South China Amifostine Consumption by Types from 2016 to 2027
-
Table South China Amifostine Consumption Share by Types from 2016 to 2027
-
Figure South China Amifostine Consumption Share by Types in 2016
-
Figure South China Amifostine Consumption Share by Types in 2021
-
Figure South China Amifostine Consumption Share by Types in 2027
-
Table South China Amifostine Consumption by End-Users from 2016 to 2027
-
Table South China Amifostine Consumption Share by End-Users from 2016 to 2027
-
Figure South China Amifostine Consumption Share by End-Users in 2016
-
Figure South China Amifostine Consumption Share by End-Users in 2021
-
Figure South China Amifostine Consumption Share by End-Users in 2027
-
Table East China Amifostine Consumption by Types from 2016 to 2027
-
Table East China Amifostine Consumption Share by Types from 2016 to 2027
-
Figure East China Amifostine Consumption Share by Types in 2016
-
Figure East China Amifostine Consumption Share by Types in 2021
-
Figure East China Amifostine Consumption Share by Types in 2027
-
Table East China Amifostine Consumption by End-Users from 2016 to 2027
-
Table East China Amifostine Consumption Share by End-Users from 2016 to 2027
-
Figure East China Amifostine Consumption Share by End-Users in 2016
-
Figure East China Amifostine Consumption Share by End-Users in 2021
-
Figure East China Amifostine Consumption Share by End-Users in 2027
-
Table Northeast China Amifostine Consumption by Types from 2016 to 2027
-
Table Northeast China Amifostine Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Amifostine Consumption Share by Types in 2016
-
Figure Northeast China Amifostine Consumption Share by Types in 2021
-
Figure Northeast China Amifostine Consumption Share by Types in 2027
-
Table Northeast China Amifostine Consumption by End-Users from 2016 to 2027
-
Table Northeast China Amifostine Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Amifostine Consumption Share by End-Users in 2016
-
Figure Northeast China Amifostine Consumption Share by End-Users in 2021
-
Figure Northeast China Amifostine Consumption Share by End-Users in 2027
-
Table Southwest China Amifostine Consumption by Types from 2016 to 2027
-
Table Southwest China Amifostine Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Amifostine Consumption Share by Types in 2016
-
Figure Southwest China Amifostine Consumption Share by Types in 2021
-
Figure Southwest China Amifostine Consumption Share by Types in 2027
-
Table Southwest China Amifostine Consumption by End-Users from 2016 to 2027
-
Table Southwest China Amifostine Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Amifostine Consumption Share by End-Users in 2016
-
Figure Southwest China Amifostine Consumption Share by End-Users in 2021
-
Figure Southwest China Amifostine Consumption Share by End-Users in 2027
-
Table Northwest China Amifostine Consumption by Types from 2016 to 2027
-
Table Northwest China Amifostine Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Amifostine Consumption Share by Types in 2016
-
Figure Northwest China Amifostine Consumption Share by Types in 2021
-
Figure Northwest China Amifostine Consumption Share by Types in 2027
-
Table Northwest China Amifostine Consumption by End-Users from 2016 to 2027
-
Table Northwest China Amifostine Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Amifostine Consumption Share by End-Users in 2016
-
Figure Northwest China Amifostine Consumption Share by End-Users in 2021
-
Figure Northwest China Amifostine Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Taj Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Taj Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Taj Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Taj Pharmaceuticals
-
Table Product and Service Introduction of Taj Pharmaceuticals
-
Table Company Profile and Development Status of Clinigen Group
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Clinigen Group
-
Figure Sales and Growth Rate Analysis of Clinigen Group
-
Figure Revenue and Market Share Analysis of Clinigen Group
-
Table Product and Service Introduction of Clinigen Group
-
Table Company Profile and Development Status of Mingren Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mingren Pharma
-
Figure Sales and Growth Rate Analysis of Mingren Pharma
-
Figure Revenue and Market Share Analysis of Mingren Pharma
-
Table Product and Service Introduction of Mingren Pharma
-
Table Company Profile and Development Status of Sun Pharmaceutical
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sun Pharmaceutical
-
Figure Sales and Growth Rate Analysis of Sun Pharmaceutical
-
Figure Revenue and Market Share Analysis of Sun Pharmaceutical
-
Table Product and Service Introduction of Sun Pharmaceutical
-
Table Company Profile and Development Status of Merro Pharmaceutical
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merro Pharmaceutical
-
Figure Sales and Growth Rate Analysis of Merro Pharmaceutical
-
Figure Revenue and Market Share Analysis of Merro Pharmaceutical
-
Table Product and Service Introduction of Merro Pharmaceutical
-
Table Company Profile and Development Status of Luye Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Luye Pharma
-
Figure Sales and Growth Rate Analysis of Luye Pharma
-
Figure Revenue and Market Share Analysis of Luye Pharma
-
Table Product and Service Introduction of Luye Pharma
-
